AU2003218359A1 - Polymer composition and dosage forms comprising the same - Google Patents

Polymer composition and dosage forms comprising the same

Info

Publication number
AU2003218359A1
AU2003218359A1 AU2003218359A AU2003218359A AU2003218359A1 AU 2003218359 A1 AU2003218359 A1 AU 2003218359A1 AU 2003218359 A AU2003218359 A AU 2003218359A AU 2003218359 A AU2003218359 A AU 2003218359A AU 2003218359 A1 AU2003218359 A1 AU 2003218359A1
Authority
AU
Australia
Prior art keywords
same
dosage forms
polymer composition
polymer
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003218359A
Other languages
English (en)
Inventor
Frank J. Bunick
Jen-Chi Chen
Harry S. Sowden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/031024 external-priority patent/WO2003026625A1/en
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Priority claimed from PCT/US2003/008960 external-priority patent/WO2004028514A1/en
Publication of AU2003218359A1 publication Critical patent/AU2003218359A1/en
Abandoned legal-status Critical Current

Links

AU2003218359A 2002-09-28 2003-03-21 Polymer composition and dosage forms comprising the same Abandoned AU2003218359A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
PCT/US2002/031024 WO2003026625A1 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031117 WO2003026629A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
AU2002334741 2002-09-28
AU2002347776 2002-09-28
PCT/US2002/031129 WO2003026630A1 (en) 2001-09-28 2002-09-28 Dosage forms having an inner core and outer shell with different shapes
AUPCT/US2002/031024 2002-09-28
PCT/US2002/031163 WO2003026627A1 (en) 2001-09-28 2002-09-28 Composite dosage forms
AU2002334743 2002-09-28
PCT/US2002/031062 WO2003026626A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
AUPCT/US2002/031129 2002-09-28
PCT/US2003/008960 WO2004028514A1 (en) 2002-09-28 2003-03-21 Polymer composition and dosage forms comprising the same

Publications (1)

Publication Number Publication Date
AU2003218359A1 true AU2003218359A1 (en) 2004-04-19

Family

ID=34271652

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2003225944A Abandoned AU2003225944A1 (en) 2002-09-28 2003-03-21 Modified release dosage forms with two cores and an opening
AU2003218359A Abandoned AU2003218359A1 (en) 2002-09-28 2003-03-21 Polymer composition and dosage forms comprising the same
AU2003220472A Abandoned AU2003220472A1 (en) 2002-09-28 2003-03-21 Modified release dosage form with two cores
AU2003220466A Abandoned AU2003220466A1 (en) 2002-09-28 2003-03-21 Delayed release dosage forms

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2003225944A Abandoned AU2003225944A1 (en) 2002-09-28 2003-03-21 Modified release dosage forms with two cores and an opening

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2003220472A Abandoned AU2003220472A1 (en) 2002-09-28 2003-03-21 Modified release dosage form with two cores
AU2003220466A Abandoned AU2003220466A1 (en) 2002-09-28 2003-03-21 Delayed release dosage forms

Country Status (8)

Country Link
JP (3) JP2006517514A (zh)
CN (3) CN1700907A (zh)
AT (1) ATE444739T1 (zh)
AU (4) AU2003225944A1 (zh)
BR (5) BR0314787A (zh)
CA (3) CA2500311A1 (zh)
DE (2) DE60329614D1 (zh)
MX (1) MXPA05003283A (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470463C (en) 2004-06-09 2012-09-18 Lornamead Brands, Inc. Tooth whitening products and methods of making the same
SA07280459B1 (ar) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP2011524891A (ja) * 2008-06-19 2011-09-08 ユニバーシティ・オブ・ジ・ウィトウォーターズランド・ヨハネスブルク 時間治療的医薬剤形
KR20130010464A (ko) * 2010-03-23 2013-01-28 아스카 세이야쿠 가부시키가이샤 고형 제제
WO2013009701A2 (en) * 2011-07-08 2013-01-17 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
WO2013119466A1 (en) * 2012-02-07 2013-08-15 Mcneil-Ppc, Inc. Rapidly disintegrating coated tablets
US9693962B2 (en) * 2012-06-05 2017-07-04 Takeda Pharmaceutical Limited Dry-coated tablet
CA2959186C (en) * 2014-09-19 2020-03-24 The Procter & Gamble Company Pulsed release phenylephrine dosage forms
KR20230079457A (ko) 2017-12-29 2023-06-07 락손 메디칼 아게 약물 전달 시스템
AU2022320730A1 (en) * 2021-07-30 2024-03-14 Evecxia Therapeutics, Inc. 5-hydroxytryptophan gastroretentive dosage forms
CN115295864B (zh) * 2021-11-09 2023-08-11 深圳市德方创域新能源科技有限公司 正极补锂添加剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662824A1 (en) * 1992-09-30 1995-07-19 Pfizer Inc. Article containing a core and a coating having a non constant thickness
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
WO2001078681A1 (fr) * 2000-04-17 2001-10-25 Yamanouchi Pharmaceutical Co., Ltd. Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant
ES2261643T3 (es) * 2001-02-13 2006-11-16 Astrazeneca Ab Nueva formulacion de liberacion modificada.

Also Published As

Publication number Publication date
AU2003220466A1 (en) 2004-04-19
JP2006517182A (ja) 2006-07-20
DE60335270D1 (de) 2011-01-20
CA2500313C (en) 2011-06-07
JP2006517514A (ja) 2006-07-27
BR0314547A (pt) 2005-08-09
AU2003225944A1 (en) 2004-04-19
MXPA05003283A (es) 2005-11-23
CA2500313A1 (en) 2004-04-08
BR0314777A (pt) 2005-07-26
BR0314804A (pt) 2005-08-02
AU2003220472A1 (en) 2004-04-19
JP2006517183A (ja) 2006-07-20
BR0314787A (pt) 2005-07-26
CN1684671A (zh) 2005-10-19
CN1700908A (zh) 2005-11-23
CA2500311A1 (en) 2004-04-08
BR0314781A (pt) 2005-07-26
DE60329614D1 (de) 2009-11-19
CN1700907A (zh) 2005-11-23
CA2500312A1 (en) 2004-04-08
ATE444739T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
AU2003227480A1 (en) Modified polymers and compositions containing the same
TWI340606B (en) Polymer compound and polymer luminous element using the same
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2003233887A1 (en) Polymers their preparation and uses
AU2003291103A1 (en) Pharmaceutical composition
AU2002350504A1 (en) Stabilized polymer composition
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
AU2003227263A1 (en) Phosphor and phosphor composition containing the same
AU2003250372A1 (en) Pharmaceutical composition
AU2002364051A1 (en) Anti-cancer combination and use thereof
AU2003293644A1 (en) Moldings and preparation and uses thereof
AU2003228205A1 (en) Porous polymers: compositions and uses thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003271183A1 (en) Block copolymer and application thereof
AU2003215257A1 (en) Modified defensins and their use
AU2003218359A1 (en) Polymer composition and dosage forms comprising the same
AU2003281687A1 (en) Photopolymerizable composition and use thereof
AU2003281620A1 (en) Copolymer and polymeric luminescent element comprising the same
AU2003298129A1 (en) Floor-furnace chimney and the use thereof
AU2003289228A1 (en) Material for fuel-system part and fuel-system part comprising the same
AU2003299943A1 (en) Heterocycles and uses thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003284460A1 (en) Medicinal composition
AU2003293939A1 (en) Polymer-containing pyrrolidone-4-carboxylic acid groups and the use thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase